1 Somatropin Market Overview

• 1.1 Product Overview and Scope of Somatropin
• 1.2 Somatropin Segment by Type
  • 1.2.1 Global Somatropin Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Powder
  • 1.2.3 Solvent
• 1.3 Somatropin Segment by Application
  • 1.3.1 Somatropin Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital Pharmacy
  • 1.3.3 Retail Pharmacy
  • 1.3.4 Online Pharmacy
• 1.4 Global Somatropin Market Size Estimates and Forecasts
  • 1.4.1 Global Somatropin Revenue 2016-2027
  • 1.4.2 Global Somatropin Sales 2016-2027
  • 1.4.3 Somatropin Market Size by Region: 2016 Versus 2021 Versus 2027

2 Somatropin Market Competition by Manufacturers

• 2.1 Global Somatropin Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Somatropin Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Somatropin Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Somatropin Manufacturing Sites, Area Served, Product Type
• 2.5 Somatropin Market Competitive Situation and Trends
  • 2.5.1 Somatropin Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Somatropin Players Market Share by Revenue
  • 2.5.3 Global Somatropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Somatropin Retrospective Market Scenario by Region

• 3.1 Global Somatropin Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Somatropin Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Somatropin Market Facts & Figures by Country
  • 3.3.1 North America Somatropin Sales by Country
  • 3.3.2 North America Somatropin Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Somatropin Market Facts & Figures by Country
  • 3.4.1 Europe Somatropin Sales by Country
  • 3.4.2 Europe Somatropin Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Somatropin Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Somatropin Sales by Region
  • 3.5.2 Asia Pacific Somatropin Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Somatropin Market Facts & Figures by Country
  • 3.6.1 Latin America Somatropin Sales by Country
  • 3.6.2 Latin America Somatropin Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Somatropin Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Somatropin Sales by Country
  • 3.7.2 Middle East and Africa Somatropin Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Somatropin Historic Market Analysis by Type

• 4.1 Global Somatropin Sales Market Share by Type (2016-2021)
• 4.2 Global Somatropin Revenue Market Share by Type (2016-2021)
• 4.3 Global Somatropin Price by Type (2016-2021)

5 Global Somatropin Historic Market Analysis by Application

• 5.1 Global Somatropin Sales Market Share by Application (2016-2021)
• 5.2 Global Somatropin Revenue Market Share by Application (2016-2021)
• 5.3 Global Somatropin Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Novo Nordisk
  • 6.1.1 Novo Nordisk Corporation Information
  • 6.1.2 Novo Nordisk Description and Business Overview
  • 6.1.3 Novo Nordisk Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Novo Nordisk Product Portfolio
  • 6.1.5 Novo Nordisk Recent Developments/Updates
• 6.2 Pfizer
  • 6.2.1 Pfizer Corporation Information
  • 6.2.2 Pfizer Description and Business Overview
  • 6.2.3 Pfizer Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Pfizer Product Portfolio
  • 6.2.5 Pfizer Recent Developments/Updates
• 6.3 Eli Lilly and Company
  • 6.3.1 Eli Lilly and Company Corporation Information
  • 6.3.2 Eli Lilly and Company Description and Business Overview
  • 6.3.3 Eli Lilly and Company Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Eli Lilly and Company Product Portfolio
  • 6.3.5 Eli Lilly and Company Recent Developments/Updates
• 6.4 GeneScience Pharmaceuticals
  • 6.4.1 GeneScience Pharmaceuticals Corporation Information
  • 6.4.2 GeneScience Pharmaceuticals Description and Business Overview
  • 6.4.3 GeneScience Pharmaceuticals Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 GeneScience Pharmaceuticals Product Portfolio
  • 6.4.5 GeneScience Pharmaceuticals Recent Developments/Updates
• 6.5 Novartis (Sandoz International)
  • 6.5.1 Novartis (Sandoz International) Corporation Information
  • 6.5.2 Novartis (Sandoz International) Description and Business Overview
  • 6.5.3 Novartis (Sandoz International) Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Novartis (Sandoz International) Product Portfolio
  • 6.5.5 Novartis (Sandoz International) Recent Developments/Updates
• 6.6 Ipsen
  • 6.6.1 Ipsen Corporation Information
  • 6.6.2 Ipsen Description and Business Overview
  • 6.6.3 Ipsen Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Ipsen Product Portfolio
  • 6.6.5 Ipsen Recent Developments/Updates
• 6.7 LG Life Sciences
  • 6.6.1 LG Life Sciences Corporation Information
  • 6.6.2 LG Life Sciences Description and Business Overview
  • 6.6.3 LG Life Sciences Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 LG Life Sciences Product Portfolio
  • 6.7.5 LG Life Sciences Recent Developments/Updates
• 6.8 Merck
  • 6.8.1 Merck Corporation Information
  • 6.8.2 Merck Description and Business Overview
  • 6.8.3 Merck Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Merck Product Portfolio
  • 6.8.5 Merck Recent Developments/Updates
• 6.9 Hoffmann-La Roche
  • 6.9.1 Hoffmann-La Roche Corporation Information
  • 6.9.2 Hoffmann-La Roche Description and Business Overview
  • 6.9.3 Hoffmann-La Roche Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Hoffmann-La Roche Product Portfolio
  • 6.9.5 Hoffmann-La Roche Recent Developments/Updates
• 6.10 Teva Pharmaceutical Industries
  • 6.10.1 Teva Pharmaceutical Industries Corporation Information
  • 6.10.2 Teva Pharmaceutical Industries Description and Business Overview
  • 6.10.3 Teva Pharmaceutical Industries Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Teva Pharmaceutical Industries Product Portfolio
  • 6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
• 6.11 Ferring Pharmaceuticals
  • 6.11.1 Ferring Pharmaceuticals Corporation Information
  • 6.11.2 Ferring Pharmaceuticals Somatropin Description and Business Overview
  • 6.11.3 Ferring Pharmaceuticals Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Ferring Pharmaceuticals Product Portfolio
  • 6.11.5 Ferring Pharmaceuticals Recent Developments/Updates
• 6.12 Anhui Anke Biotechnology
  • 6.12.1 Anhui Anke Biotechnology Corporation Information
  • 6.12.2 Anhui Anke Biotechnology Somatropin Description and Business Overview
  • 6.12.3 Anhui Anke Biotechnology Somatropin Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Anhui Anke Biotechnology Product Portfolio
  • 6.12.5 Anhui Anke Biotechnology Recent Developments/Updates

7 Somatropin Manufacturing Cost Analysis

• 7.1 Somatropin Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Somatropin
• 7.4 Somatropin Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Somatropin Distributors List
• 8.3 Somatropin Customers

9 Somatropin Market Dynamics

• 9.1 Somatropin Industry Trends
• 9.2 Somatropin Growth Drivers
• 9.3 Somatropin Market Challenges
• 9.4 Somatropin Market Restraints

10 Global Market Forecast

• 10.1 Somatropin Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Somatropin by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Somatropin by Type (2022-2027)
• 10.2 Somatropin Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Somatropin by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Somatropin by Application (2022-2027)
• 10.3 Somatropin Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Somatropin by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Somatropin by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Powder
Solvent

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Novo Nordisk
Pfizer
Eli Lilly and Company
GeneScience Pharmaceuticals
Novartis (Sandoz International)
Ipsen
LG Life Sciences
Merck
Hoffmann-La Roche
Teva Pharmaceutical Industries
Ferring Pharmaceuticals
Anhui Anke Biotechnology